For pharmaceutical and biotech companies ... would need to be considered further by the European Parliament and the Council of Ministers in the hope of implementing guidance and addressing ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

The 21st century pharmaceutical and biotech sector has ... took place in the broader landscape of the post-war boom, a general context of massive improvements in standards of living and ...